Topamax (topiramate) is now approved to PREVENT migraines
Topamax (topiramate) is now approved to PREVENT migraines.
Nearly half of patients have 50% fewer migraines while on Topamax. This is comparable to current preventive drugs such as tricyclics...divalproex...and beta-blockers.
Patients start on 25 mg/day, then slowly increase up to 50 to 100 mg BID. This is lower than the dose used for seizures.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote